Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts

Fig. 4

Promoter activities of Per2 and Bik under MTX treatment. Synovial fibroblasts transfected with vectors containing various Per2 or Bik promoters for 24 h. After treatment with MTX (10, 100 nM) or control media for 24 h, luciferase reporter assay was performed. Promoter activities of MTX-untreated cells defined as 1.0, and each value shown relative to control. Values are mean ± SEM. *p < 0.05, #p < 0.1, n = 5 (Per2), n = 6 (Bik). Bik Bcl-2 interacting killer, MTX methotrexate, Per period

Back to article page